Clinical Trial: A Single-arm, Open, Exploratory Clinical Study of Allogeneic CAR-T Cells in the Treatment of Relapsed/refractory Brain Gliomas with Positive CD70 Expression

U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06828341) titled 'A Single-arm, Open, Exploratory Clinical Study of Allogeneic CAR-T Cells in the Treatment of Relapsed/refractory Brain Gliomas with Positive CD70 Expression' on Feb. 10.

Brief Summary: The goal of this clinical trial is to learn if allogeneic CAR-T cells can treat patients with advanced gliomas. The main questions it aims to answer are:

Evaluate the safety of allogeneic CAR-T cells in the treatment of advanced gliomas.

To evaluate the effectiveness of allogeneic CAR-T cells in the treatment of advanced gliomas and to study its immunological properties in patients.

Study Start Date: June 13, 2024

Study Type: INTERVENTIONAL

Condi...